Clover Health Investments, Corp.
CLOV
$3.66
$0.205.78%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 330.68M | 322.58M | 349.90M | 341.72M | 303.75M |
| Total Other Revenue | 6.28M | 8.41M | 6.36M | 4.73M | 4.59M |
| Total Revenue | 336.96M | 330.99M | 356.26M | 346.46M | 308.34M |
| Cost of Revenue | 243.04M | 249.77M | 248.35M | 265.16M | 249.75M |
| Gross Profit | 93.92M | 81.21M | 107.91M | 81.29M | 58.59M |
| SG&A Expenses | 115.02M | 90.20M | 99.92M | 103.79M | 107.88M |
| Depreciation & Amortization | 344.00K | 339.00K | 330.00K | 318.00K | 674.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 358.41M | 340.31M | 348.60M | 369.27M | 358.31M |
| Operating Income | -21.45M | -9.32M | 7.66M | -22.82M | -49.96M |
| Income Before Tax | -21.48M | -8.79M | 7.17M | -23.17M | -67.95M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -21.48M | -8.79M | 7.17M | -23.17M | -67.95M |
| Earnings from Discontinued Operations | -611.00K | -370.00K | 238.00K | 4.00M | -2.53M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -22.09M | -9.16M | 7.41M | -19.17M | -70.47M |
| EBIT | -21.45M | -9.32M | 7.66M | -22.82M | -49.96M |
| EBITDA | -21.10M | -8.98M | 7.99M | -22.50M | -49.29M |
| EPS Basic | -0.04 | -0.02 | 0.02 | -0.04 | -0.15 |
| Normalized Basic EPS | -0.03 | -0.01 | 0.01 | -0.03 | -0.07 |
| EPS Diluted | -0.05 | -0.02 | 0.01 | -0.04 | -0.15 |
| Normalized Diluted EPS | -0.03 | -0.01 | 0.01 | -0.03 | -0.07 |
| Average Basic Shares Outstanding | 491.87M | 490.18M | 487.48M | 486.37M | 481.61M |
| Average Diluted Shares Outstanding | 491.87M | 490.18M | 495.18M | 486.37M | 481.61M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
